Litigation Details for Bayer Intellectual Property GMBH v. Aurobindo Pharma Limited (D. Del. 2017)
✉ Email this page to a colleague
Bayer Intellectual Property GMBH v. Aurobindo Pharma Limited (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-04-28 |
Court | District Court, D. Delaware | Date Terminated | 2017-11-29 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 9,539,218 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Bayer Intellectual Property GMBH v. Aurobindo Pharma Limited
Details for Bayer Intellectual Property GMBH v. Aurobindo Pharma Limited (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-04-28 | 1 | FDA. 22. U.S. Patent No. 9,539,218 (“the ’218 patent”), entitled “Prevention and Treatment…products prior to the expiration of U.S. Patent No. 9,539,218. … 1. This is an action for patent infringement under the patent laws of the United States, Title…forth in greater detail in the ’218 patent, the claims of the ’218 patent, incorporated by reference herein…the ’218 patent. 25. Bayer AG is an exclusive licensee under the ’218 patent. | External link to document | |
2020-12-29 | 33 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2. (Attachments: #… 22 December 2020 1:17-cv-00483 830 Patent None District Court, D. Delaware | External link to document |
2017-04-28 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2. (ceg) (Entered:… 30 November 2017 1:17-cv-00483 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |